Benedetta Fabrizzi

430 total citations
20 papers, 151 citations indexed

About

Benedetta Fabrizzi is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Epidemiology. According to data from OpenAlex, Benedetta Fabrizzi has authored 20 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 4 papers in Genetics and 4 papers in Epidemiology. Recurrent topics in Benedetta Fabrizzi's work include Cystic Fibrosis Research Advances (12 papers), Tracheal and airway disorders (9 papers) and Neonatal Respiratory Health Research (7 papers). Benedetta Fabrizzi is often cited by papers focused on Cystic Fibrosis Research Advances (12 papers), Tracheal and airway disorders (9 papers) and Neonatal Respiratory Health Research (7 papers). Benedetta Fabrizzi collaborates with scholars based in Italy, United States and France. Benedetta Fabrizzi's co-authors include Marco Lucarelli, Vito Terlizzi, Rita Padoan, Giuseppe Cimino, Laura Claut, Giovanni Taccetti, Antonella Tosco, Valentino Bezzerri, Seth J. Corey and Giovanni Sette and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Benedetta Fabrizzi

18 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benedetta Fabrizzi Italy 8 105 23 21 14 14 20 151
David W. Shia United States 5 77 0.7× 26 1.1× 41 2.0× 6 0.4× 11 0.8× 5 146
E. Girodon France 5 168 1.6× 34 1.5× 24 1.1× 19 1.4× 10 0.7× 10 209
Bénédicte Romefort France 6 49 0.5× 37 1.6× 15 0.7× 11 0.8× 6 0.4× 10 95
Johanna Jimenez United States 5 48 0.5× 13 0.6× 39 1.9× 18 1.3× 5 0.4× 10 116
Iris Scheffen Germany 4 34 0.3× 15 0.7× 45 2.1× 14 1.0× 20 1.4× 8 188
J.E. Peabody Lever United States 8 123 1.2× 15 0.7× 56 2.7× 12 0.9× 37 2.6× 20 211
M. G. Benetazzo Italy 4 196 1.9× 40 1.7× 24 1.1× 12 0.9× 14 1.0× 4 226
Nicola Pozzi Italy 6 27 0.3× 17 0.7× 19 0.9× 25 1.8× 36 2.6× 11 124
Hữu Vĩnh Vũ Vietnam 7 53 0.5× 51 2.2× 19 0.9× 6 0.4× 46 3.3× 16 150
Marco Bobbo Italy 6 21 0.2× 12 0.5× 18 0.9× 8 0.6× 7 0.5× 21 81

Countries citing papers authored by Benedetta Fabrizzi

Since Specialization
Citations

This map shows the geographic impact of Benedetta Fabrizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benedetta Fabrizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benedetta Fabrizzi more than expected).

Fields of papers citing papers by Benedetta Fabrizzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benedetta Fabrizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benedetta Fabrizzi. The network helps show where Benedetta Fabrizzi may publish in the future.

Co-authorship network of co-authors of Benedetta Fabrizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Benedetta Fabrizzi. A scholar is included among the top collaborators of Benedetta Fabrizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benedetta Fabrizzi. Benedetta Fabrizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castellani, Carlo, Fredrick Van Goor, Benedetta Fabrizzi, et al.. (2026). Elexacaftor/tezacaftor/ivacaftor for cystic fibrosis and rare CFTR variants: in vitro translation to a phase 3, double-blind, randomized, placebo-controlled trial, and real-world study. American Journal of Respiratory and Critical Care Medicine. 212(2). 327–337.
2.
Durieu, I., Barry Clements, Benedetta Fabrizzi, et al.. (2025). Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(10). 1926–1934. 1 indexed citations
3.
Volpi, Sonia, et al.. (2025). Elexacaftor/Tezacaftor/Ivacaftor Efficacy in a Cohort of Italian Patients with CFTR Rare Mutations. SHILAP Revista de lepidopterología. 5(1). 11–11.
4.
Cirilli, Natalia, Rosaria Gesuita, Luca Tiano, et al.. (2024). Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy. Journal of Cystic Fibrosis. 23(6). 1153–1158. 2 indexed citations
5.
6.
Gramegna, Andrea, Stefano Aliberti, Maria Adelaide Calderazzo, et al.. (2023). The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus. Respiratory Medicine. 220. 107455–107455. 4 indexed citations
7.
Dolce, Daniela, Antonella Tosco, Rita Padoan, et al.. (2023). Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age. European Journal of Pediatrics. 183(2). 929–938. 4 indexed citations
8.
Dolce, Daniela, Laura Claut, Carla Colombo, et al.. (2022). Different management approaches and outcome for infants with an inconclusive diagnosis following newborn screening for cystic fibrosis (CRMS/CFSPID) and Pseudomonas aeruginosa isolation. Journal of Cystic Fibrosis. 22(1). 73–78. 12 indexed citations
9.
10.
Sette, Giovanni, Valentina Salvati, Germana Castelli, et al.. (2021). Theratyping cystic fibrosisin vitroin ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells. European Respiratory Journal. 58(6). 2100908–2100908. 41 indexed citations
11.
Menditto, Vincenzo G., Federico Mei, Benedetta Fabrizzi, & Martina Bonifazi. (2021). Role of bronchoscopy in critically ill patients managed in intermediate care units - indications and complications: A narrative review. World Journal of Critical Care Medicine. 10(6). 334–344. 3 indexed citations
12.
Terlizzi, Vito, Laura Claut, Carla Colombo, et al.. (2021). Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator‐related metabolic syndrome/CF screen‐positive, inconclusive diagnosis. Pediatric Pulmonology. 56(12). 3785–3791. 12 indexed citations
13.
Vella, Antonio, Elisabetta D’Aversa, Giulia Breveglieri, et al.. (2020). mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment. Cancers. 12(3). 597–597. 17 indexed citations
14.
Terlizzi, Vito, Rita Padoan, Laura Claut, et al.. (2020). CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?. Diagnostics. 10(12). 1080–1080. 14 indexed citations
15.
Bezzerri, Valentino, et al.. (2020). Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes. International Journal of Molecular Sciences. 21(13). 4672–4672. 7 indexed citations
16.
Fabrizzi, Benedetta, Giuseppe Cimino, Natalia Cirilli, et al.. (2019). Two novel and correlated CF-causing insertions in the (TG)mTn tract of the CFTR gene. PLoS ONE. 14(10). e0222838–e0222838. 2 indexed citations
17.
Bezzerri, Valentino, Antonio Vella, Gianfranco Di Gennaro, et al.. (2019). Peripheral blood immunophenotyping in a large cohort of patients with Shwachman–Diamond syndrome. Pediatric Blood & Cancer. 66(5). e27597–e27597. 6 indexed citations
18.
Bezzerri, Valentino, Antonio Vella, Elisabetta D’Aversa, et al.. (2019). Breakthroughs in Preclinical Development of Ataluren (PTC124) As Therapeutic Option for Patients Affected By Shwachman-Diamond Syndrome: Towards the First Clinical Trial. Blood. 134(Supplement_1). 451–451. 1 indexed citations
19.
Galante, Dario, et al.. (2012). Optimal Position of A Long-Term Central Venous Catheter Tip in A Pediatric Patient with Congenital Diseases. Pediatric Reports. 4(3). e32–e32. 3 indexed citations
20.
Fabrizzi, Benedetta, et al.. (2007). Cystic adenomatoid malformation in children: CT histopathological correlation. La radiologia medica. 112(4). 612–619. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David W. Shia Breakdown of academic impact, for papers by E. Girodon Breakdown of academic impact, for papers by Bénédicte Romefort Breakdown of academic impact, for papers by Johanna Jimenez Breakdown of academic impact, for papers by Iris Scheffen Breakdown of academic impact, for papers by J.E. Peabody Lever Breakdown of academic impact, for papers by M. G. Benetazzo Breakdown of academic impact, for papers by Nicola Pozzi Breakdown of academic impact, for papers by Hữu Vĩnh Vũ Breakdown of academic impact, for papers by Marco Bobbo
Rankless by CCL
2026